持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/09/09 | 日証協 | 119,939株 | -3.17% | 45,787株 | -29.08% | 116,161株 | -1.4% | 29,239株 | -30.73% |
2016/09/02 | 日証協 | 123,868株 | -1.82% | 64,566株 | +40.39% | 117,811株 | -7.1% | 42,212株 | +122.15% |
2016/08/26 | 日証協 | 126,168株 | +1.61% | 45,989株 | +45.11% | 126,810株 | -0.69% | 19,002株 | -12.46% |
2016/08/19 | 日証協 | 124,170株 | +5.07% | 31,693株 | +26.27% | 127,691株 | +1.75% | 21,706株 | -26.76% |
2016/08/12 | 日証協 | 118,181株 | -14.03% | 25,100株 | -45.21% | 125,491株 | +6.04% | 29,637株 | -33.01% |
2016/08/05 | 日証協 | 137,468株 | +8.36% | 45,812株 | -4.89% | 118,341株 | +4.59% | 44,243株 | +171.43% |
2016/07/29 | 日証協 | 126,867株 | -3.24% | 48,165株 | -4.96% | 113,145株 | -1.63% | 16,300株 | +32.06% |
2016/07/22 | 日証協 | 131,112株 | +16.11% | 50,676株 | +26.08% | 115,019株 | -1.22% | 12,343株 | -21.66% |
2016/07/15 | 日証協 | 112,919株 | -12.63% | 40,192株 | +41.18% | 116,443株 | -6.35% | 15,756株 | +4.23% |
2016/07/08 | 日証協 | 129,236株 | -8.47% | 28,469株 | -27.07% | 124,343株 | -7.87% | 15,117株 | -26.85% |
2016/07/01 | 日証協 | 141,192株 | +2.65% | 39,035株 | -49.79% | 134,970株 | +10.73% | 20,665株 | +5.48% |
2016/06/24 | 日証協 | 137,550株 | -0.59% | 77,750株 | -1.56% | 121,894株 | -7.71% | 19,591株 | -23.57% |
2016/06/17 | 日証協 | 138,360株 | -1.73% | 78,986株 | -1.51% | 132,072株 | +5.14% | 25,634株 | +64.32% |
2016/06/10 | 日証協 | 140,791株 | +2.37% | 80,200株 | +122.31% | 125,615株 | +5.7% | 15,600株 | -30.39% |
2016/06/03 | 日証協 | 137,533株 | -2.43% | 36,075株 | -53.43% | 118,846株 | -10.81% | 22,412株 | -3.58% |
2016/05/27 | 日証協 | 140,961株 | -5.08% | 77,456株 | +12.4% | 133,246株 | -0.16% | 23,243株 | -18.28% |
2016/05/20 | 日証協 | 148,501株 | +5.66% | 68,911株 | +39.26% | 133,460株 | +15.43% | 28,443株 | +62.53% |
2016/05/13 | 日証協 | 140,544株 | +7.15% | 49,482株 | -9.33% | 115,617株 | +6.35% | 17,500株 | +121.52% |
2016/05/06 | 日証協 | 131,167株 | +24.01% | 54,574株 | -2.65% | 108,717株 | +21.21% | 7,900株 | -72.56% |
※株式分割は考慮していませんのでご注意ください。
Page Top